Data Analysis and Classification of Cardiovascular Disease and Risk Factors Associated with It in India

  • Sonia SinglaEmail author
  • Sanket Sathe
  • Pinaki Nath Chowdhury
  • Suman Mishra
  • Dhirendra Kumar
  • Meenakshi Pawar
Part of the Studies in Computational Intelligence book series (SCI, volume 875)


Cardiovascular disease (CVD) is one of the genuine reasons behind mortality in India and around the globe. A high measure of sodium, high circulatory strain, extend, smoking, family parentage and a few different variables are related to heart illnesses. Air and Noise Pollution is also worst in India and is likely to cause more deaths, amongst the top five causes of deaths worldwide, are the heart, COPD, lower respiratory infections, and lung cancer. In India absence of information, and treatment facilities in that of rural and urban zones are the critical issue of concern. Youths have more chances of getting impacted with CVD, due to alcohol usage, smoking, and unfortunate eating routine. In the future, in India by 2030, the prevalence rate might rise to two-fold than 2018. This overview goes for researching progressing propels in understanding the investigation of infection transmission of CVD, causes and the hazard factors related to it. One of the continuous patterns in cardiology at present is the proposed use of man-made consciousness (AI) in increasing and broadening the adequacy of the cardiologist. This is on the grounds that AI or AI would take into consideration an exact proportion of patient working and conclusion from the earliest starting point up to the part of the bargain procedure. Specifically, the utilization of computerized reasoning in cardiology plans to concentrate on innovative work, clinical practice, and populace wellbeing. Made to be an across the board instrument in cardiovascular social insurance, AI innovations consolidate complex calculations in deciding significant advances required for a fruitful finding and treatment. The job of man-made reasoning explicitly reaches out to the recognizable proof of novel medication treatments, illness stratification or insights, persistent remote observing and diagnostics, reconciliation of multi-omic information, and expansion of doctor effectivity and effectiveness. Virtual reality developed during the 1990s in the realm of computer games and has been gradually crawling into medication from that point onward. Today, several specialists are investigating how VR can help treat everything from agoraphobia to consume wounds to stroke. Research recommends utilizing an augmented experience interface can help improve development and coordination of the arms, hands and fingers in stroke survivors.


India Ordinariness Rate Mortality CVD Smoking Hypertension Medicines Diet and nutrients Air pollution Data analysis Virtual reality Artificial intelligence Stroke 


  1. 1.
    Verma, A., Mehta, S., Mehta, A., & Patyal, A. (2019). Knowledge, attitude and practices toward health behavior and cardiovascular disease risk factors among the patients of metabolic syndrome in a teaching hospital in India. Journal of Family Medicine and Primary Care On Web, 8(1), 178–183.CrossRefGoogle Scholar
  2. 2.
    Singh, S., Shankar, R., & Singh, G. P. (2017). Prevalence and associated risk factors of hypertension: A cross-sectional study in urban Varanasi. International Journal of Hypertension, 2017, 5491838.CrossRefGoogle Scholar
  3. 3.
    European Institute of Women’s Health, E. (2013). Gender and Chronic Disease Policy Briefings. European Institute of Women’s Health.Google Scholar
  4. 4.
    Sekhri, T., Kanwar, R. S., Wilfred, R., Chugh, P., Chhillar, M., Aggarwal, R., et al. (2014). Prevalence of risk factors for coronary artery disease in an urban Indian population. BMJ Open, 4, e005346.CrossRefGoogle Scholar
  5. 5.
    Marbaniang, I. P., Kadam, D., Suman, R., Gupte, N., Salvi, S., Patil, S., et al. (2017). Cardiovascular risk in an HIV-infected population in India. Heart Asia, 9, e010893.CrossRefGoogle Scholar
  6. 6.
    Sunitha, S., Gururaj, G. (2014). Health behaviours & problems among young people in India: Cause for concern & call for action. Indian Journal of Medical Research, 140, 185–208.Google Scholar
  7. 7.
    Chaturvedi, N. (2003). Ethnic differences in cardiovascular disease. Heart, 89, 681–686.CrossRefGoogle Scholar
  8. 8.
    Khairnar, V. D., Saroj, A., Yadav, P., Shete, S., & Bhatt, N. (2019) Primary Healthcare Using Artificial Intelligence. In: Bhattacharyya S., Hassanien A., Gupta D., Khanna A., Pan I. (eds) International Conference on Innovative Computing and Communications. Lecture Notes in Networks and Systems, vol 56. Springer, Singapore.Google Scholar
  9. 9.
    Murthy, K. J. R. (2005). Economic burden of chronic obstructive pulmonary disease. In A. Indrayan, (Ed.) Burden of Disease in India, p. 264.Google Scholar
  10. 10.
    Chauhan, S., Aeri, D. (2013). Prevalence of cardiovascular disease in India and its economic impact—A review. International Journal of Scientific Research. 3.Google Scholar
  11. 11.
    Engelgau, M. M., Karan, A., & Mahal, A. (2012). The economic impact of non-communicable diseases on households in India. Global Health, 8, 9.CrossRefGoogle Scholar
  12. 12.
    Schnell, O., & Standl, E. (2006). Impaired glucose tolerance, diabetes, and cardiovascular disease. Endocrine Practice, 12(Suppl 1), 16–19.CrossRefGoogle Scholar
  13. 13.
    Swain, S., Pati, S., & Pati, S. (2017). A chart review of morbidity patterns among adult patients attending primary care setting in urban Odisha, India: An international classification of primary care experience. Journal of Family Medicine and Primary Care On Web, 6, 316–322.CrossRefGoogle Scholar
  14. 14.
    British Heart Foundation, B.H.F. Medicines for Heart Conditions—Treatments—British Heart Foundation.
  15. 15.
    Mirza, N., Ganguly, B. (2016). Utilization of medicines available at home by general population of rural and urban set up of Western India. Journal of Clinical and Diagnostic Research, 10, FC05–FC09.Google Scholar
  16. 16.
    Latest News, Breaking News Live, Current Headlines, India News Online | The Indian Express.
  17. 17.
  18. 18.
    Khetan, A., Zullo, M., Hejjaji, V., Barbhaya, D., Agarwal, S., Gupta, R., et al. (2017). Prevalence and pattern of cardiovascular risk factors in a population in India. Heart Asia, 9, e010931.CrossRefGoogle Scholar
  19. 19.
    Shah, B., & Mathur, P. (2010). Surveillance of cardiovascular disease risk factors in India: The need & scope. Indian Journal of Medical Research, 132, 634–642.Google Scholar
  20. 20.
    Oommen, A. M., Abraham, V. J., George, K., & Jose, V. J. (2016). Prevalence of coronary heart disease in rural and urban Vellore: A repeat cross-sectional survey. Indian Heart Journal, 68, 473–479.CrossRefGoogle Scholar
  21. 21.
    Prabhakaran, D., Roy, A., Praveen, P. A., Ramakrishnan, L., Gupta, R., Amarchand, R., et al. (2017). 20-Year trend of CVD risk factors: Urban and rural national capital region of India. Global Heart, 12, 209–217.CrossRefGoogle Scholar
  22. 22.
    Srivatsa, U. N., Swaminathan, K., Sithy Athiya Munavarah, K., Amsterdam, E., Shantaraman, K. (2016). Sudden cardiac death in South India: Incidence, risk factors and pathology. Indian Pacing and Electrophysiology Journal, 16, 121–125.CrossRefGoogle Scholar
  23. 23.
    Das, S. K., Banerjee, T. K., Biswas, A., Roy, T., Raut, D. K., Mukherjee, C. S., et al. (2007). A prospective community-based study of stroke in Kolkata. Indian Stroke, 38, 906–910.CrossRefGoogle Scholar
  24. 24.
    Bhagyalaxmi, A., Atul, T., & Shikha, J. (2013). Prevalence of risk factors of non-communicable diseases in a District of Gujarat, India. Journal of Health, Population and Nutrition, 31, 78–85.CrossRefGoogle Scholar
  25. 25.
    Use v, control. (2013). Perceptions of young male smokers. International Journal of Research Development and Health.Google Scholar
  26. 26.
    Bani T Aeri, D. S. (2014). Risk factors associated with the increasing cardiovascular diseases prevalence in India: A review. Journal of Nutrition and Food Sciences, 05.Google Scholar
  27. 27.
    American Lung Association: What’s In a Cigarette? | American Lung Association,
  28. 28.
    Smoking and Cardiovascular Health: This fact sheet is for public health officials and others who are interested in how smoking affects the heart and circulatory system. Smoking is very dangerous to’ ‘ cardiovascular health. Smoking and Cardiovascular Health. (2014).Google Scholar
  29. 29.
    Chadda, R. K., & Sengupta, S. N. (2003). Tobacco use by Indian adolescents. Tobacco Induced Diseases, 1, 8.CrossRefGoogle Scholar
  30. 30.
    Narain, R., Sardana, S., Gupta, S., & Sehgal, A. (2011). Age at initiation & prevalence of tobacco use among school children in Noida, India: A cross-sectional questionnaire based survey. Indian Journal of Medical Research, 133, 300–307.Google Scholar
  31. 31.
    Gupta, R., Xavier, D. (2018). Hypertension: The most important non-communicable disease risk factor in India. Indian Heart Journal.Google Scholar
  32. 32.
    Allen, L., Williams, J., Townsend, N., Mikkelsen, B., Roberts, N., Foster, C., et al. (2017). Socioeconomic status and non-communicable disease behavioural risk factors in low-income and lower-middle-income countries: A systematic review. The Lancet Global Health, 5, e277–e289.CrossRefGoogle Scholar
  33. 33.
    O’Donnell, M. J., Mente, A., Smyth, A., & Yusuf, S. (2013). Salt intake and cardiovascular disease: Why are the data inconsistent? European Heart Journal, 34, 1034–1040.CrossRefGoogle Scholar
  34. 34.
    Cappuccio, F. P. (2013). Cardiovascular and other effects of salt consumption. Kidney International Supplements, 2011(3), 312–315.CrossRefGoogle Scholar
  35. 35.
    Nayana, A., Amudha, T. (2019). A computational study on air pollution assessment modeling. In S. Bhattacharyya, A. Hassanien, D. Gupta, A. Khanna, I. Pan, (Eds.) International Conference on Innovative Computing and Communications. Lecture Notes in Networks and Systems, Vol. 56. Singapore: Springer.Google Scholar
  36. 36.
    Shah, A. S. V., Langrish, J. P., Nair, H., McAllister, D. A., Hunter, A. L., Donaldson, K., et al. (2013). Global association of air pollution and heart failure: A systematic review and meta- analysis. Lancet, 382, 1039–1048.CrossRefGoogle Scholar
  37. 37.
    National Air Quality Index.
  38. 38.
  39. 39.
    Abbey, M., Owen, A., Suzakawa, M., Roach, P., & Nestel, P. J. (1999). Effects of menopause and hormone replacement therapy on plasma lipids, lipoproteins and LDL-receptor activity. Maturitas, 33, 259–269.CrossRefGoogle Scholar
  40. 40.
    Kinra, S., Bowen, L. J., Lyngdoh, T., Prabhakaran, D., Reddy, K. S., Ramakrishnan, L., et al. (2010). Sociodemographic patterning of non-communicable disease risk factors in rural India: A cross sectional study. BMJ, 341, c4974.CrossRefGoogle Scholar
  41. 41.
    Ormel, J., Von Korff, M., Burger, H., Scott, K., Demyttenaere, K., Huang, Y., et al. (2007). Mental disorders among persons with heart disease—Results from world mental health surveys. General Hospital Psychiatry, 29, 325–334.CrossRefGoogle Scholar
  42. 42.
    Michael, A. J., Krishnaswamy, S., Muthusamy, T. S., Yusuf, K., & Mohamed, J. (2005). Anxiety, depression and psychosocial stress in patients with cardiac events. Malaysian Journal of Medical Sciences, 12, 57–63.Google Scholar
  43. 43.
    Sahoo, K. C., Hulland, K. R. S., Caruso, B. A., Swain, R., Freeman, M. C., Panigrahi, P., et al. (2015). Sanitation-related psychosocial stress: A grounded theory study of women across the life-course in Odisha, India. Social Science and Medicine, 139, 80–89.CrossRefGoogle Scholar
  44. 44.
    Kavi, A., Walvekar, P. R., & Patil, R. S. (2019). Biological risk factors for coronary artery disease among adults residing in rural area of North Karnataka, India. Journal of Family Medicine and Primary Care On Web, 8(1), 148–153.CrossRefGoogle Scholar
  45. 45.
    Kumar, M. (2018). Classification of heart diseases patients using data mining techniques. IJRECE, 6.Google Scholar
  46. 46.
    Angiotensin-converting enzyme (ACE) inhibitors - Mayo Clinic [Internet]. [cited 2018 Mar 7]. Available from:
  47. 47.
    Angiotensin II receptor blockers—Mayo Clinic [Internet]. [cited 2018 Mar 7]. Available from:
  48. 48.
  49. 49.
    Anticoagulant medicines—NHS.UK [Internet]. [cited 2018 Mar 11]. Available from:
  50. 50.
    Knight, C. J. (2003). Antiplatelet treatment in stable coronary artery disease. Heart, 89(10), 1273–1278.CrossRefGoogle Scholar
  51. 51.
    Boudonas, G. E. (2010). β-blockers in coronary artery disease management. Hippokratia, 14(4), 231–235.Google Scholar
  52. 52.
    Heart Disease and Yoga [Internet]. [cited 2019 Apr 4]. Available from:
  53. 53.
    Atorvastatin | C33H35FN2O5—PubChem [Internet]. [cited 2018 Mar 7]. Available from:
  54. 54.
    Digoxin | Heart and Stroke Foundation [Internet]. [cited 2018 Mar 11]. Available from:
  55. 55.
    NHS. Electrocardiogram (ECG)—NHS.UK [Internet]. 2015 [cited 2018 Feb 26]. Available from:
  56. 56.
    Cardiac, Heart MRI [Internet]. [cited 2018 Feb 26]. Available from:
  57. 57.
    Angiography—NHS.UK [Internet]. 2017 [cited 2018 Feb 27]. Available from:
  58. 58.
    Thompson-Butel, A. G., Shiner, C. T., McGhee, J., Bailey, B. J., Bou-Haidar, P., McCorriston, M., et al. (2019). The role of personalized virtual reality in education for patients post stroke-a qualitative case series. Journal of Stroke and Cerebrovascular Diseases, 28, 450–457.CrossRefGoogle Scholar
  59. 59.
    Pacher, P., & Kecskemeti, V. (2004). Cardiovascular side effects of new antidepressants and antipsychotics: New drugs, old concerns? Current Pharmaceutical Design, 10(20), 2463–2475.CrossRefGoogle Scholar
  60. 60.
    Arrhythmia—NHS.UK [Internet]. [cited 2018 Feb 28]. Available from:
  61. 61.
    Coronary heart disease—NHS.UK [Internet]. [cited 2018 Feb 28]. Available from:
  62. 62.
    Heart failure—NHS.UK [Internet]. [cited 2018 Feb 28]. Available from:
  63. 63.
    Gupta, R., Joshi, P., Mohan, V., Reddy, K. S., & Yusuf, S. (2008). Epidemiology and causation of coronary heart disease and stroke in India. Heart, 94(1), 16–26.CrossRefGoogle Scholar
  64. 64.
    Holt, S. (2014). Cochrane corner: Yoga to prevent cardiovascular disease. Advances in Integrative Medicine, 1(3), 150.CrossRefGoogle Scholar
  65. 65.
    Prabhakaran, D., Jeemon, P., & Roy, A. (2016). Cardiovascular diseases in India: Current epidemiology and future directions. Circulation, 133, 1605–1620.CrossRefGoogle Scholar
  66. 66.
    Pullen, P. R., Seffens, W. S., & Thompson, W. R. (2018). Yoga for heart failure: A review and future research. International Journal of Yoga, 11(2), 91–98.CrossRefGoogle Scholar
  67. 67.
    Haider, T., Sharma, M., & Branscum, P. (2017). Yoga as an alternative and complimentary therapy for cardiovascular disease: A systematic review. Journal of Evidence Based Complementary & Alternative Medicine, 22(2), 310–316.CrossRefGoogle Scholar
  68. 68.
    India | Institute for Health Metrics and Evaluation [Internet]. [cited 2019 Apr 4]. Available from:

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Sonia Singla
    • 1
    Email author
  • Sanket Sathe
    • 2
  • Pinaki Nath Chowdhury
    • 3
  • Suman Mishra
    • 4
  • Dhirendra Kumar
    • 5
  • Meenakshi Pawar
    • 6
  1. 1.University of LeicesterLeicesterUK
  2. 2.Savitribai Phule Pune UniversityPuneIndia
  3. 3.Kalyani Government Engineering CollegeKalyaniIndia
  4. 4.School of Biotechnology and BioinformaticsD.Y. Patil UniversityNavi MumbaiIndia
  5. 5.Translational Health Science and Technology InstituteFaridabadIndia
  6. 6.MIMER Medical CollegeTalegaon DabhadeIndia

Personalised recommendations